Pegaspargase
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 305 publications
Economic burden associated with switching from frontline pegaspargase or calaspargase pegol to second-line recombinant Erwinia in pediatrics and adolescents/young adults with acute lymphoblastic leukemia.
Journal: Journal of medical economics
Published: May 21, 2026
Aggressive NK-cell leukemia with CD5(+)CD10(-) monoclonal B cell lymphocytosis and hemophagocytic lymphohistiocytosis: a case report and literature review
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 20, 2026
Immune-Mediated IgA Nephropathy Induced by PD-1 Blockade in Extranodal NK/T-Cell Lymphoma.
Journal: International medical case reports journal
Published: January 26, 2026
Daratumumab-based salvage therapy enables umbilical cord blood transplantation in multiline refractory, elderly T-lymphoblastic lymphoma: a case report.
Journal: Frontiers in immunology
Published: November 10, 2025
Assessing the clinical and economic impact of delayed versus early pegaspargase.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 30, 2025
Natural Killer/T-Cell Lymphoma-Associated Hemophagocytic lymphohistiocytosis-a Rare and Dangerous Disease.
Journal: Blood and lymphatic cancer : targets and therapy
Published: October 15, 2025
Early diagnosis of extranodal NK/T lymphoma presenting with oral ulcer and lip swelling by metagenomics next-generation sequencing: a case report.
Journal: BMC oral health
Published: September 29, 2025
Pegaspargase-associated cerebral venous sinus thrombosis: risk factors and anticoagulation management in pediatric acute lymphoblastic leukemia-a case series.
Journal: Translational pediatrics
Published: September 28, 2025
Last Updated: 06/30/2026